100% of moneycontrol users recommend buying Wanbury.
What's your call on Wanbury today?
Read Investor view
|Company Name||Last Price||%
|Dr Reddys Labs||3200.60||-0.88||3353.85||2420.00||54,527.29|
|Dec' 13||Sep' 13||Jun' 13||Mar' 13|
|No Mutual Funds Holding the share|
National Buildings Constr Recommended on Jul 14th 2014
Recommended price 396.00 | Peak from reco 767.50 93.69%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Wanbury is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 87.37 crore.The company has reported a standalone sales of Rs 115.12 crore and a Net Profit of Rs 1.28 crore for the quarter ended Jun 2014.
The company management includes K Chandran - Vice Chairman, A L Bongirwar - Ind. Non-Executive Director, N K Puri - Ind. Non-Executive Director, P L Tiwari - Ind. Non-Executive Director, Manish Joshi - Nominee Director, S K Bhattacharyya - Additional Director.
It is listed on the BSE with a BSE Code of 524212 and the NSE with an NSE Code of WANBURY.
Its Registered office is at B Wing, BSEL Techpark, 10th Floor, Sector 30A,,Opp Vashi Railway Station, Mumbai,Maharashtra - 400705.
Their Registrars are Sharex Dynamic (India) Pvt. Ltd.